NCT06707064

Brief Summary

This study aims to evaluate the impact of the Self-Family-Environment Empowerment (SFEE) diet management intervention on glycemic control, maternal outcomes, and dietary adherence in pregnant women with gestational diabetes mellitus (GDM).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2024

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

November 23, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 27, 2024

Completed
Last Updated

November 27, 2024

Status Verified

November 1, 2024

Enrollment Period

1 year

First QC Date

November 23, 2024

Last Update Submit

November 26, 2024

Conditions

Keywords

Gestational Diabetes Mellitus, SFEE Diet Management, Glycemic Control, Maternal Outcomes, Dietary Adherence

Outcome Measures

Primary Outcomes (2)

  • Glycemic Control (Fasting Blood Glucose Levels)

    Change in fasting blood glucose levels (measured in mmol/L) from baseline to the end of the 3-month intervention period. This measure evaluates the effectiveness of the SFEE diet management intervention in improving blood glucose regulation in gestational diabetes mellitus.

    Baseline and 3 months post-intervention

  • Glycemic Control (HbA1c Levels)

    Change in HbA1c levels (measured in %) from baseline to the end of the 3-month intervention period. This measure assesses the long-term blood sugar control improvements resulting from the SFEE diet management intervention compared to standard dietary advice.

    Baseline and 3 months post-intervention

Secondary Outcomes (3)

  • Dietary Adherence

    Baseline and 3 months post-intervention

  • GDM Knowledge

    Baseline and 3 months post-intervention

  • Perceived Social Support

    Baseline and 3 months post-intervention

Study Arms (2)

SFEE Diet Management Group ( Experimental Arm)

EXPERIMENTAL

Participants in this group received the Self-Family-Environment Empowerment (SFEE) diet management intervention, which included: Self-empowerment: Goal-setting, dietary planning, and evaluation. Family empowerment: Emotional support and supervision of dietary practices. Environmental empowerment: Peer group interaction, education, and support through WeChat groups. Routine nursing care was also provided alongside the intervention.

Behavioral: SFEE Diet Management Intervention

Control Group

ACTIVE COMPARATOR

Participants in this group received routine nursing care for gestational diabetes management, including: Medication guidance, dietary education using guidance charts, exercise plans, and self-monitoring. Dietary plans were customized based on individual patient needs, but no additional empowerment strategies (e.g., SFEE) were implemented.

Behavioral: Standard Dietary Advice

Interventions

A structured diet management program designed to improve glycemic control, dietary adherence, and maternal outcomes. It includes: Self-empowerment: Goal-setting, dietary planning, and evaluation. Family empowerment: Emotional support and supervision. Environmental empowerment: Peer group interaction and education via WeChat groups and in-person meetings.

SFEE Diet Management Group ( Experimental Arm)

Routine nursing care, including dietary education, exercise planning, and self-monitoring for gestational diabetes management.

Control Group

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Diagnosed with gestational diabetes mellitus (GDM) based on the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria.
  • Aged 18-45 years.
  • Pregnant women between 24-28 weeks of gestation at the time of enrollment.
  • Able to provide informed consent.
  • Access to a mobile phone and internet for study communication and follow-up.

You may not qualify if:

  • Pregnant women with complications such as placental abruption, miscarriage, or induced abortion during the study period.
  • Those unable to give informed consent or adhere to the intervention due to medical or personal reasons.
  • History of severe medical conditions or other factors that might interfere with study participation (e.g., severe mental health conditions).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Hospital of Shanxi Medical University

Taiyuan, Shanxi, 030001, China

Location

Related Links

MeSH Terms

Conditions

Diabetes, Gestational

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Li Jun, Doctorate

    The First Affiliated Hospital of Shanxi Medical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessors were blinded to minimize bias during data collection and analysis. Participants and care providers were not masked due to the nature of the intervention.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants were assigned to either the SFEE intervention group or a control group receiving standard dietary advice in a 1:1 allocation ratio.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Head of Nurse Department

Study Record Dates

First Submitted

November 23, 2024

First Posted

November 27, 2024

Study Start

March 1, 2023

Primary Completion

March 1, 2024

Study Completion

March 31, 2024

Last Updated

November 27, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared as there is no provision for data sharing in the current study design, and ethical approval for data sharing has not been obtained. Researchers requiring data can contact the corresponding author for potential collaboration or data access requests in compliance with institutional and ethical guidelines

Available IPD Datasets

Study Protocol (2022-K205)Access

Locations